Article Details
Retrieved on: 2022-05-01 20:16:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Equities analysts forecast that Arbutus Biopharma Co. (NASDAQ:ABUS - Get Rating) will post ($0.13) earnings per share (EPS) for the current fiscal ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here